Singh Gurinder Bir, Cowan Douglas B, Wang Da-Zhi
Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
Front Oncol. 2020 Nov 23;10:598964. doi: 10.3389/fonc.2020.598964. eCollection 2020.
Skeletal muscles are the largest tissues in our body and the physiological function of muscle is essential to every aspect of life. The regulation of development, homeostasis, and metabolism is critical for the proper functioning of skeletal muscle. Consequently, understanding the processes involved in the regulation of myogenesis is of great interest. Non-coding RNAs especially microRNAs (miRNAs) are important regulators of gene expression and function. MiRNAs are small (~22 nucleotides long) noncoding RNAs known to negatively regulate target gene expression post-transcriptionally and are abundantly expressed in skeletal muscle. Gain- and loss-of function studies have revealed important roles of this class of small molecules in muscle biology and disease. In this review, we summarize the latest research that explores the role of miRNAs in skeletal muscle development, gene expression, and function as well as in muscle disorders like sarcopenia and Duchenne muscular dystrophy (DMD). Continuing with the theme of the current review series, we also briefly discuss the role of miRNAs in cancer cachexia.
骨骼肌是人体最大的组织,肌肉的生理功能对生命的各个方面都至关重要。肌肉发育、稳态和代谢的调节对于骨骼肌的正常功能至关重要。因此,了解参与肌生成调节的过程备受关注。非编码RNA尤其是微小RNA(miRNA)是基因表达和功能的重要调节因子。miRNA是小的(约22个核苷酸长)非编码RNA,已知在转录后负调节靶基因表达,并且在骨骼肌中大量表达。功能获得和功能丧失研究揭示了这类小分子在肌肉生物学和疾病中的重要作用。在本综述中,我们总结了探索miRNA在骨骼肌发育、基因表达、功能以及在肌肉减少症和杜氏肌营养不良症(DMD)等肌肉疾病中的作用的最新研究。延续本综述系列的主题,我们还简要讨论了miRNA在癌症恶病质中的作用。